Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Alteogen decided to hold its 16th Annual General Meeting of Shareholders on March 26, 2024, at the Daejeon Convention Center to vote on agenda items including financial statement approval, director/auditor appointments, and stock option grants.
📊 [Key Disclosure Details & Financial Highlights]
- Type of Meeting: Annual General Meeting of Shareholders
- Date, Time & Venue:
- Date & Time: March 26, 2024, 09:00 AM (KST)
- Venue: Medium Conference Hall (1F), Daejeon Convention Center, 107 Expo-ro, Yuseong-gu, Daejeon
- Key Agenda Items:
- Report Items: Audit Report, Business Report, Report on Operational Status of Internal Accounting Control System
- Agenda Item 1: Approval of Financial Statements & Consolidated Financial Statements for the 16th Fiscal Year
- Agenda Item 2: Appointment of Directors (2-1: Executive Director Taeyeon Jun / 2-2: Outside Director In Young Ko / 2-3: Outside Director Sang Chul Lee)
- Agenda Item 3: Appointment of Standing Auditor Byung Kyu Lee
- Agenda Item 4: Approval of Director Remuneration Limit
- Agenda Item 5: Approval of Auditor Remuneration Limit
- Agenda Item 6: Approval of Granting Stock Options
- Details of Nominated Executives:
- Executive Director Candidate Taeyeon Jun (New, 3-year term): Current Vice President (CAO) of ALTEOGEN, US Patent Attorney
- Outside Director Candidate In Young Ko (Re-appointment, 3-year term): Current Outside Director of ALTEOGEN, Professor at Kangwon National University
- Outside Director Candidate Sang Chul Lee (New): Vice President of KSBMB, Former Director of NRF
- Standing Auditor Candidate Byung Kyu Lee (Re-appointment, 3-year term): Current Standing Auditor of ALTEOGEN
- Board Resolution Date: 2024-03-11 (2 Outside Directors attended, Auditor attended)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Why Verifying AGM Results and Voting Outcomes Is Necessary
This filing is an informational disclosure notifying the schedule and proposed agendas for the upcoming Annual General Meeting of Shareholders.
Checking this follow-up item is necessary because it is essential to verify whether the proposed agendas are officially voted upon and approved as submitted on the scheduled meeting date (March 26, 2024). Since the final approval of financial statements, executive appointments, and stock option authorizations is decided on the meeting day, confirming that the voting outcomes are accurately disclosed in the subsequent results filing is necessary to ensure the final verification of the disclosed facts.
The final voting results can be verified in upcoming disclosures or periodic reports on DART.
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
